Acquired CD20 Loss as a Mechanism of Resistance to Mosunetuzumab in Relapsed Follicular Lymphoma . (2026). Mediterranean Journal of Hematology and Infectious Diseases, 18(1), e2026014. https://doi.org/10.4084/MJHID.2026.014